Total Flex Triple Action
Natural health product licensed in Canada
- Licence holder
- Quinsis Biotech Corporation
- NPN or DIN-HM
- 80094239
- Status
- Active licence
- Licence date
- 4 September 2019
- Revision date
- 31 August 2022
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Terminalia chebula Source : Fruit Potency : 12 % Chebulagic acid | Not specified | Not calculated |
| Terminalia chebula Source : Fruit Potency : 15 % Chebulinic acid | Not specified | Not calculated |
| Acide hyaluronique Source : Streptococcus equi - capsule extracellulaire bactérienne | 10 mg | Not calculated |
| Acide hyaluronique Source : Hyaluronate de sodium | 10 mg | Not calculated |
Non-medicinal ingredients
Hypromellose, Silice, Cellulose microcristalline, Palmitate d'ascorbyle, Gomme de cellulose, Esters d'acide gras de poly(glycérol), Amidon de maïs modifié, Tocophérols, Stéarate de magnésium, Dextrine, Gomme arabique, NA
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | 2 days |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps reduce pain associated with osteoarthritis. Helps to reduce stiffness associated with osteoarthritis. Helps to relieve joint pain associated with osteoarthritis. Helps to relieve pain associated with osteoarthritis of the knee. Helps to reduce joint pain associated with osteoarthritis. Helps to reduce stiffness associated with osteoarthritis. Helps to relieve joint pain and stiffness associated with osteoarthritis. Helps to reduce blood C reactive protein levels, a clinical marker of inflammation. Starts to help reduce pain at 5 days. Source of/Provides antioxidants. Helps support eye health. Helps reduce eye strain and eye fatigue.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80094239
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging